Orkla ASA (ORK) Earnings Call Transcript & Summary

October 26, 2023

Oslo Bors NO Consumer Staples Food Products earnings 44 min

Earnings Call Speaker Segments

Kari Lindtvedt

executive
#1

Good morning, everyone, and welcome to the presentation of Orkla's third quarter results. I'm Kari Lindtvedt, Head of Investor Relations. As we usually do, we'll begin today with our President and CEO, Nils Selte, who will offer some reflections on the quarter as well as on the transaction announced earlier today. After him, our CFO, Harald Ullevoldsæter, will walk you through more detail on the financials for the quarter. At the close of the presentation, Nils will share and summarize our main messages from today before we move on to Q&A. Also joining us today in the Q&A session will be Investment Executive Øyvind Torpp, who is here to answer any additional questions you might have about the transaction we announced this morning. Throughout today's presentation, please feel free to pose questions on the webcast, and we will address them at the end of the presentations. With that, I'll leave the floor to you, Nils.

Nils Selte

executive
#2

Thank you, Kari, and good morning, everyone, and thanks for being with us on the presentation. First, as Kari mentioned, I'd like to offer a few remarks on the transaction we announced this morning. It's a great pleasure and a point of pride to announce that we have signed a partnership agreement with Rhône regarding Orkla Food Ingredients. Since its founding back in 1999, Orkla Food Ingredients has expanded ninefold and has become a leading provider of food ingredient solutions in the bakery, ice cream ingredients, and plant-based categories. That growth stems from organic expansion and a successful M&A strategy, with over 50 acquisitions across Europe and North America. Over time, Orkla Food Ingredients has proven to be a resilient business, successfully navigating economic downturns and recent macroeconomic disturbances. When we began the process last year of finding a partner for Orkla Food Ingredients, our ambition was to identify someone with relevant industry experience who could support and contribute to Orkla Food Ingredients' growth and value creation. We conducted a thorough search and saw strong interest from a wide range of potential partners. Today, we are very happy to announce that this partner is Rhône. Through past and current investments, Rhône focuses on, and has experience from, the consumer sector and the food and beverage industry.

Nils Selte

executive
#3

Rhône is a worldwide private equity company that was founded in 1996 and invests in businesses with operations on both sides of the Atlantic. Over the years, they've produced robust financial returns and built a demonstrated record of generating considerable value for their owners and partners. Through the partnership with Rhône, Orkla Food Ingredients will be able to remain at the leading edge of industry consolidation, with a clear goal of enhancing margins and carrying on its growth journey. Rhône and Orkla are both entirely dedicated and aligned with the plan for greater value creation ahead. Following the transaction, Orkla will hold 60% and Rhône 40% of Orkla Food Ingredients. The implied enterprise value of the company in this transaction stands at NOK 15.5 billion. In my view, this transaction is a very good illustration of how Orkla's new operating model underpins our value creation. The new operating model gives us more flexibility regarding ownership models and our capacity to execute. As Kari mentioned, Øyvind will be with us during the Q&A session to help address any questions regarding the transaction. There's one slide missing here... Since at this point I was meant to be discussing this one. Before I comment on the financials for Q3, I'd like to remind everyone about our upcoming Capital Markets Day in London in November.

Nils Selte

executive
#4

To give you a quick sense of the agenda, the day is split into two parts. During the first part, the focus will be on Orkla ASA's overall strategy as an industrial investment company, our ownership role, and financial strategy. We'll spend time explaining why the new operating model will create more value, and how it does so. In part two, the six most important portfolio companies will be on stage, setting out their ambitions, financial targets, unique value drivers, and strategies. As a general remark, most targets and ambitions will be presented at portfolio company level. That matches our new operating model, in which value is created through the underlying performance of each portfolio company. That's the reason we've increased transparency in quarterly reporting since Q2 this year. We will, however, also comment on our group level ambition for value creation under the new operating model and provide some guidance on selected group targets. The agenda will run for approximately four hours, and I hope to see as many of you as possible in London at that event... Now let's dig into the quarterly performance for the group and our portfolio companies.

Nils Selte

executive
#5

To begin with the group, today we’re reporting a decline of 14% in adjusted group EBIT. That reflects the profit drop in hydropower, which took a heavy hit from lower prices versus the same quarter a year ago. Early in the year, we began a strong push on generating cash flow across the whole group, and I’m pleased that this is showing up more and more in the figures we’ve provided for Q3. Turning to our portfolio companies, we can report continued EBIT adjusted growth at eight of 12 portfolio companies. Let me point to the strong results at Jotun, Orkla India, Orkla Home and Personal Care, and Orkla Health. Orkla Confectionery & Snacks is still wrestling with the ramp-up of the new biscuit factory, and we’ve seen that we underestimated both the complexity and the drawn-out financial effects. Those difficulties will stay with us into 2024 as well. The hit to earnings for this quarter is estimated at NOK 40 million. I truly regret that we didn’t spot this sooner, which would have let us be more precise in what we reported to the market. On the brighter side, underlying performance across the rest of Orkla Confectionery & Snacks is rather solid. We also had an extraordinary event in Orkla Foods Europe — the recall of ketchup from our Swedish factory because of quality issues.

Nils Selte

executive
#6

The costs involved come to NOK 25 million. I can assure you that this matter was resolved during the quarter. As a final point, adjusted earnings per share rose 2% in the quarter, reaching NOK 1.61. We also announced today that Pål Jordal, CEO of Orkla Foods Europe, has chosen to leave his position effective first of November. Atle Vidar Nagel-Johansen will serve as interim CEO as we look for his successor. During that interim period, Atle Vidar will step away from Orkla's management team. With that, I'll now hand things over to Harald, who will walk you through the Q3 details.

Harald Ullevoldsæter

executive
#7

Thanks, Nils, and good morning, everyone. I'll walk you through the quarter three results now, and like last time, the focus will mainly be on the aggregated figures and the eight largest portfolio companies. Group reported revenue growth came in at 14% for the quarter. For the consolidated portfolio companies, organic growth was 6%, driven mainly by price increases of 7.8%, while volume mix was down 1.8%. Considering the hoarding effect in quarter two last year, which benefited this quarter three this year, volume performance is broadly in line with prior quarters, maybe a slight improvement. EBIT adjusted for the consolidated portfolio companies rose by 16%, and earnings growth was broad-based, with price increases as the main driver. Adjusted for changes in Forex exchange rates and M&A, underlying growth was 5%. The tailwind to our customers from price increases is smaller in quarter three and will be for the remainder of this year. As we entered the summer, we saw heightened risk that prices for important agricultural products would rise again because of drought and reduced crops, as we communicated in our Q2 presentation. That has not materialized to any substantial degree, but geopolitics and the effects of extreme weather, such as the ongoing El Niño, remain an unknown for supply and input costs ahead.

Harald Ullevoldsæter

executive
#8

Input costs are still rising versus the same quarter a year ago. Prices in the market for a weighted basket of our key materials went down in quarter two, yet in quarter three they have shown a more stable pattern, owing to wider polarization of market prices. Market prices for materials including vegetable oils, grain-based products, and dairy are below last year's levels, but in categories such as cocoa, tomato paste, rice, and fruits we are seeing market prices rising in an adverse way. The drop in financial investment came mainly from electricity prices for hydropower. In Norway, electricity prices during the quarter amounted to only a fraction of last year's levels. That gave EBIT adjusted of NOK 153 million for hydropower. Under the state budget for 2024, a proposal has been made to remove the windfall tax that was brought in last year and that affects hydropower. Handover of apartments in real estate from Orkla Brands' former headquarters in Oslo lifted EBIT by NOK 91 million for financial investments. Net other income and expenses for the quarter came to NOK -77 million. The biggest items were write-downs of Czech brand and intangibles within the European Pizza Company, which were offset by a positive reversal stemming from the exit of Hamé, Russia.

Harald Ullevoldsæter

executive
#9

Turning to associates, profit from associates came in at NOK 509 million, driven mainly by a strong performance at Jotun, as Nils mentioned. I'll return to that. Net financial items were higher than last year, primarily because of increased interest cost, but also a higher debt level. The average interest rate for the quarter was 5.4%, versus 2.6% in the same period a year ago. Reported tax expenses were NOK 430 million. That's down from NOK 685 million in the corresponding quarter last year. The underlying tax rate, adjusted for hydropower, tax, and other non-deductible cost, was basically unchanged at approximately 22%. Let's take a look at cash flow for the first 9 months. Total cash flow from operation was NOK 4.8 billion in the first 9 months of 2023, compared to NOK 2.2 billion for the same period last year. Cash flow from operation in the consolidated portfolio companies was significantly higher than in 2022. This was mainly driven by improved earnings and a less negative change in net working capital from lower inventory. Parts of these improvements are related to our increased focus on capital, and our ambition is still to reduce working capital to a more normalized level.

Harald Ullevoldsæter

executive
#10

The biggest item among net replacement investments was building the new biscuit factory in Latvia. Other factory projects are also part of replacement investment. Now I'll take you through the net interest-bearing debt bridge for the first nine months of 2023. Net debt, leases included, rose by NOK 2.8 billion to NOK 19.9 billion from year-end 2022, yet it fell by NOK 2.8 billion versus quarter two. Taxes paid during the first nine months come to NOK 1.6 billion, higher than in the same period a year earlier, and that reflects higher hydropower profit in 2022 being paid in 2023. In April we also distributed NOK 3 billion as dividend. Net M&A and expansion CapEx amounted to NOK 1.3 billion in the first nine months of 2023, mainly tied to the acquisition of Bubs Godis in Sweden and Khell-Food in Hungary. Expansion CapEx accounted for NOK 452 million in the period, against NOK 228 million in the same period last year. Negative currency translation effects from a weaker NOK pushed the net debt level up by NOK 1.1 billion. Orkla's financial position is sound, and our net debt level at the close of quarter three equals 2x EBITDA, calculated on the last twelve months with acquired businesses included in EBITDA.

Harald Ullevoldsæter

executive
#11

That’s down from 2.3 in quarter two. Let’s now take a somewhat closer look at how the portfolio companies performed, beginning with Jotun. At Jotun, underlying volume growth continued, average selling prices were higher, and a positive mix delivered strong top-line growth. Every segment contributed to that growth. Strong sales growth, together with a higher gross margin and good cost control, produced an increase in operating profit. EBITDA was up 50% in the third quarter. Jotun expects additional sales growth over the rest of the year. Still, year-over-year growth rates should come in lower, since last year had strong comparison months. Raw material prices have leveled off after falling since the second half of 2022. Cheaper raw materials are expected to keep driving a year-on-year margin improvement in the coming quarter. Inflationary pressure on other operating expenses in a number of markets partly offsets this. Next, let’s look at Orkla Foods Europe. Orkla Foods Europe posted organic sales growth of 4.4% in the third quarter. That growth was price-driven and broad-based in the grocery channel, while volumes fell across most markets. The volume mix decline of -5.4% is mainly tied to reduced purchasing power and higher consumer prices.

Harald Ullevoldsæter

executive
#12

This impacts how consumers behave, with hard discounters picking up share and promotions fueling customer activity. Grocery channel market shares fell during the period, mainly in Sweden and Denmark. That ties back to the purchasing pattern shift I mentioned. Food service and convenience continue to show a positive sales trend... However, the high cost of raw materials and packaging is still a challenge. Because of the weighted exposure across different procurement categories, the cost increases hit Orkla Foods Europe harder than other portfolio companies. Examples of raw materials seeing significant increases include meat, dairy, sugar, tomato paste, and rice. Beyond that, glass and metals are big packaging categories with strong price increases. Underlying EBIT adjusted rose 5%, mostly driven by price increases, offset by cost increases and negative volume performance. A ketchup recall in several markets hurt the quarter, but about NOK 25 million as a result of higher cost and lost sales. Turning to Orkla Food Ingredients. Orkla Food Ingredients posted organic sales growth of 4.2% in the quarter. That growth was price-driven, as the volume mix of -1.1% shows, mainly driven by the bakery and ice cream segments. To sum up, the ice cream season this year was weak because of unfavorable weather across large parts of Europe during July and August.

Harald Ullevoldsæter

executive
#13

Price contributed favorably this quarter, though more slowly than in earlier periods, since we saw fewer price hikes in 2023 now that commodity prices have leveled off. In quarter three, volume growth remained positive in plant-based drinkables and margarine. Margarine especially will run into tougher comparables in quarter four. Our underlying EBIT adjusted margin shrank 0.5 percentage point versus a year ago. The causes were negative mix effects from strong sales of low-cost products in certain markets, along with higher costs. Many of our companies still deliver solid profit growth, and both the bakery and plant-based segments are growing too, but a weak ice cream season, as I noted, plus other costs offset that. Let's now turn to how Orkla Confectionery & Snacks performed. Organic sales at Orkla Confectionery & Snacks grew 7.1%, with price accounting for 10.1% of that. The 3% volume decline stemmed from delivery challenges at the new biscuit plant in Latvia. With that factored in, volume mix is roughly flat. Starting up the new biscuit factory in Latvia has proven harder and more complex than we expected, as Nils said.

Harald Ullevoldsæter

executive
#14

The problems we've faced have stemmed from specific technical matters, along with the handover of know-how to the new plant. Output has risen over the last quarter, and we expect the facility to hit its planned production volume during the fourth quarter. That said, the higher volume has come with costs above what we had projected. The ramp-up difficulties have hurt both cost and sales performance, and taken together, we estimate the negative earnings impact at roughly NOK 40 million for the quarter and NOK 125 million year to date, including lost sales as well. We expect this situation to last through the fourth quarter and into the beginning of 2024. Market shares have dipped slightly, and one key reason is obviously the weak service level at our new biscuit factory. Earnings development across the rest of the business, excluding biscuits — the rest of the business, sorry, excluding biscuits — was solid in the quarter. Raw material costs are flattening out gradually across most purchasing categories, though they remain above the level seen in the same period a year earlier. For some key input costs, such as cocoa and sugar, prices have risen and will keep rising into 2024.

Harald Ullevoldsæter

executive
#15

The weak Norwegian krone and Swedish krona are hurting procurement costs overall. Now let's turn to Orkla Health. Orkla Health posted 6.6% organic growth in the quarter. That growth came from both price and volume increases in the health and wound care categories. It was combined with widespread subscription growth for NutraQ. The market share picture was mixed in quarter three. Vitamins, minerals, and supplements moved ahead slightly weakly in the grocery channel, as private label keeps gaining shares. Underlying EBIT adjusted rose 7.3%, lifted by sales growth but partly offset by higher fixed costs and increased AMP. The EBIT margin fell back to 15.4%, versus 16% in the same period last year, because of negative mix effects. Let's now go on to Orkla India. Orkla India grew organically by 12.1% in the quarter, driven by both price and volume... Growth was broad-based across core categories, both domestically and internationally. The underlying EBIT adjusted increase of 33.2% came from both higher sales and an improved contribution margin. Commodity prices were stable during the quarter. Please note that profit got a positive boost from a government grant of NOK 6.5 million under an incentive program for Indian food producers.

Harald Ullevoldsæter

executive
#16

I'd also like to remind everyone that the MTR and Eastern merger became effective on 1st of September this year. Orkla holds 90.01% ownership in the combined entity, consistent with what was announced in connection with the Eastern acquisition. Turning now to Orkla Home and Personal Care. That business delivered solid growth, especially in Norway, driven by a healthy combination of price and volume. Organic growth came in at 11.4%. The contribution ratio saw improvement thanks to price increases, though this was offset by elevated input costs, primarily stemming from a weaker Norwegian krone. Part of that improvement was tied to high transportation costs and one-off expenses incurred last year. Most input factors carry Euro exposure, so the weakening of the Norwegian krone from last year has a negative impact. Adjusted EBIT was likewise hurt by higher depreciations reflecting the relatively high investment level last year, yet it still stands at twice last year's level. Moving on to our pizza franchise business. The European Pizza Company lifted revenues by 28%, with 5.4% of that organic, and the gap reflects the positive consolidation effect from the Da Grasso acquisition in Poland plus favorable currency translation effects.

Harald Ullevoldsæter

executive
#17

Higher consumer sales along with price hikes in the wholesale operation gave sales a lift. Consumer sales came to EUR 111 million in quarter three, an underlying gain of 2.2%. Outside Germany, consumer sales showed underlying growth of 7.2%. Acquiring the converting pizza chains in Germany has turned out to be a complicated strategy. The reasons include a franchise network that was weaker than anticipated, poor brand recognition, and a broadly difficult macro environment. A restructuring has begun in Germany, with a number of underperforming outlets shut down so as to secure a firmer platform and a leaner organization moving forward. Next, a quick look at the other four companies. Those four businesses are smaller, and further details about them appear regularly in the quarterly financial report. I'll now pass it back to Nils for his closing comments.

Nils Selte

executive
#18

Thanks, Harald. A few quick remarks from me before we take questions. First, we're really enthusiastic about teaming up with Rhône. That tie-up will make Orkla Food Ingredients stronger, with a clear goal of building shareholder value via volume growth, better margins, capital efficiency, and structural growth. Turning to our Q3 reporting, I'm pleased that underlying growth shows up across most of our portfolio companies, with gains on key parameters and cost-improvement initiatives tracking to plan. Let me add that conditions remain turbulent, and our value chain — from input factors through to consumers' buying power — is feeling the impact. Looking ahead, we must concentrate on volume and margin and keep investing in AMP for our brands so they stay relevant. The drawn-out, difficult ramp-up of the new biscuit factory at Orkla Confectionery & Snacks is not acceptable, and mitigation is a top priority. Volume is improving, but we expect elevated costs to persist into 2024. Lastly, I look forward to sharing more on our ambitions and new operating model at our Capital Markets Day in London in late November. Back to you, Kari, and we'll open the Q&A.

Kari Lindtvedt

executive
#19

Thank you. And as we noted, Øyvind Torpp is also with us for today's Q&A. So I'll begin by checking whether anyone in the audience has a question. Please give your name and company.

Analyst

analyst
#20

I'm Sigurd Sanna, a stockholder. Given the troubles in Latvia, is Orkla also going to put its next factory there?

Nils Selte

executive
#21

This is what—

Analyst

analyst
#22

Regarding the proceeds from the Rhône transaction — I find it somewhat odd that Orkla's portfolio doesn't include coffee. How about acquiring a few coffee brands? Coffee is hot right now.

Sigurd Sanna

unknown
#23

I'll begin with the factory issues in Latvia. First off, I believe it has been more than 20 years since we last constructed a facility of this scale within Orkla, within the Orkla system. This has nothing to do with Latvia whatsoever; it actually stems from building this plant during the COVID period. The consequence was that we fell significantly behind schedule, and we lost some very key employees during that time, so we lost competence. So for sure, this is not a Latvia matter. The COVID situation has had an impact on it. And at present we have plenty of people working to resolve this problem.

Nils Selte

executive
#24

We believe we're in good shape going forward, and we now have a dedicated type of task force in place to address it, though it will take time. There are 13 production lines that must run without interruption, and it's fairly complicated. As for the net proceeds from the Orkla Food transaction, specifically regarding Orkla Food Ingredients, of course we'll carefully consider how to invest, and whether to invest at all. But what we're saying is that Orkla Food Ingredients will keep doing M&A under the new partnership, so we've now earmarked capital for that purpose moving ahead. On coffee — perhaps we should look at that going forward. I think it's very important to note that we've now set up a new way of running Orkla. I think it's very important that we demonstrate this model delivers more value to our shareholders before we begin putting that much money into new categories or new platform investments at Orkla.

Kari Lindtvedt

executive
#25

Thanks. Are there any more questions from the audience? All right, then we also have a few questions submitted online. The first comes from Ole Martin Westgaard at DNB. He's got three questions, and I'll go through them one by one. Organic growth has been quite strong over the last couple of quarters, driven by price, while volumes have been soft. As price increases ease, how should we think about volume development?

Nils Selte

executive
#26

Like we've consistently said, we don't provide guidance for future periods. That said, as I mentioned, we'll keep putting money into A&P to back our brands across the whole portfolio. That's certain. Still, from my perspective, what the past year or these quarters have shown us is a trend of consumers purchasing products at a sort of hard discount store. That pattern kicked off in Czechia, essentially 12 months ago. It carried on into Sweden and Denmark, and at this point we're seeing a few indications of that sort of shift in Finland as well. Our thinking is that when people — when purchasing power is coming back to consumers — they'll go back to the more supermarket-type formats, and that should help us recover volume.

Harald Ullevoldsæter

executive
#27

Maybe I could just add something—

Nils Selte

executive
#28

Sure.

Harald Ullevoldsæter

executive
#29

A few remarks. On the volume side, I'd say the toughest piece has been the Orkla Foods portfolio. When you look across recent quarters, the drop in volume has stayed roughly at that same level. And since quarter three of last year, we've been quite explicit that our biggest challenge and biggest risk looking ahead is how volumes develop. So dealing with that sits high on our agenda.

Kari Lindtvedt

executive
#30

Yes, thanks. And now for Ole Martin's second question: could you say something about how you view the competitive landscape and how your market share is developing across the key segments?

Nils Selte

executive
#31

I believe it's essentially very similar to what I already said. I think, I think if, if you look at Norway, we don't have hard discounters there. In Norway, we see that we're sort of holding onto our market share. But we see that, in the other markets, as I mentioned, Czechia, Denmark, Sweden, Finland, we see that hard discounters are gaining share. They're, they're more kind of private label in that, those formats, and I think that, that is hitting our market share, short term. Hopefully, if this turn around, we, we will gain back market share over time, but who knows when that will happen?

Kari Lindtvedt

executive
#32

I’m not certain. All right, Ole Martin has one last question: could you give us some detail about the specific items you plan to give guidance on at our Capital Markets Day — that is, your Capital Markets Day?

Nils Selte

executive
#33

I'd say we'll save that for the Capital Markets Day. There's a plan in place. We'll certainly revisit it on 29 November. I think we'll stick with what I said — we'll provide some guidance on certain financial figures at the group level, but I'll leave that for the Capital Markets Day.

Kari Lindtvedt

executive
#34

Okay, thanks. So we've got a couple of questions coming from Håkon Fuglu. The first one is: could you say something about what risk the new weight loss drugs might pose, and has any effect shown up in your markets so far?

Nils Selte

executive
#35

At this point, I don’t believe we’re seeing any impact in our markets. Of course, we take this very seriously. We’re trying to understand the effect and the future effect on our portfolio, but I think it’s fair to say that we have a fairly broad-based portfolio of different categories across the different portfolio companies, and we’ve said before, and we’ll keep saying, that we want to grow in health. I think in the markets where this product is affecting the market, what you see is that the consumer turns to more healthier product. I think we’re in a good position in that regard.

Kari Lindtvedt

executive
#36

Thanks. Our next question comes from Håkon Fuglu: what was the effect of currency on the contribution margin in the current year?

Øyvind Torpp

executive
#37

Currency has played a significant role when it comes to the contribution margin. The weaker NOK and the weaker SEK matter a lot, but I don't think I can get into the specifics of what the actual impact on the contribution margin has been.

Kari Lindtvedt

executive
#38

Thanks. Now, two additional questions come from Ole Martin at DNB. The first one is this: of that NOK 1 billion cost-reduction program, how much has actually been achieved so far?

Øyvind Torpp

executive
#39

All I can say is that the overall cost program has us quite pleased. It is proceeding as scheduled, and we have solid examples along with strong initiatives — a new one dating from last Christmas, particularly at Orkla Foods Europe, where three major projects are underway. We can see their impact reflected in this quarter's figures, and further favorable effects should keep showing up in quarter four and on into the years ahead. So yes, we are pleased.

Kari Lindtvedt

executive
#40

Okay, and the second question is again from Ole Martin. It's about the partnership we announced this morning: how much expertise does Rhône actually bring, and in what way could they speed up development at OFI?

Nils Selte

executive
#41

I'll begin, and perhaps Øyvind can add some detail. First, though, as I mentioned during my presentation, Rhône has generated substantial value via its various investments going back to the late 1990s, in fact. So, to my mind, they arrive at this as capable businesspeople — that matters a great deal, I believe. Second, they've put money into the very sector where OFI does business, and they, they haven't always been that successful, but they entered this process with a strongly positive outlook and also certain specialists whom they intend to install on the board, and we believe those people will genuinely help Orkla Food Ingredients develop as we move ahead. So perhaps you could add to that, Øyvind-

Øyvind Torpp

executive
#42

Yes.

Nils Selte

executive
#43

I'd like to hear how you see things, given that you'll be chairman down the road.

Øyvind Torpp

executive
#44

To start, I'm genuinely thrilled to share this news and to have the chance to discuss it. At the outset of this process, our goals were very clear: we wanted a partner possessing particular industry know-how, along with a demonstrated history in partnerships of this type. We sought someone who has faith in OFI's distinctive business model and in the business plan as well, and then naturally we also wanted a commercially appealing deal from Orkla. As Nils said, Rhône brings specific industry expertise. Board members will join OFI, for instance Marianne Kirkegaard. In similar situations and partnerships previously, they have shown that they add to both the operational agenda and the structural agenda. I've been fortunate enough to speak with many companies that have entered partnerships with Rhône, and the feedback from those other companies has been very positive. So I'm eagerly anticipating working with Rhône.

Kari Lindtvedt

executive
#45

Thanks. Next up is a question from Abhishek Parikh, who isn't with any company, and here's what he asks: Are there any M&A plans for Orkla India?

Nils Selte

executive
#46

I'd say Orkla India is well placed to keep hunting for M&A candidates. That said, I think it's fair to note that I don't really see this particular event coming. And when we acquired Eastern, that deal involved both a cash payment to the seller and shares in Orkla India. So we'll stay pragmatic about how we approach M&A going forward, provided there's a solid transaction worth pursuing. We'll also look at using something other than cash to settle any M&A deals, should that be on the agenda. But one thing's certain: we don't. We're constantly on the lookout for good opportunities across all the portfolio companies.

Kari Lindtvedt

executive
#47

Appreciate it.

Øyvind Torpp

executive
#48

Mm.

Kari Lindtvedt

executive
#49

So, we've got three questions coming from Patrick Folan at Barclays. To start, it seems like private label pressure is lighter than it was in Q2, since you brought it up less in this release. Is that right?

Øyvind Torpp

executive
#50

No, private label pressure is roughly at the same level we saw in quarter two and quarter one.

Kari Lindtvedt

executive
#51

Thanks. On the second question: in any markets this quarter, has pricing elasticity or pressure from consumers turned into more of a problem?

Øyvind Torpp

executive
#52

I'd say that within Orkla Foods, the volume challenges are concentrated in the same markets, namely Sweden, Denmark, and Czechia. That pattern held in quarter one and quarter two as well.

Kari Lindtvedt

executive
#53

Thanks. One final question, again about the partnership: how does your view of the business shift when it comes to the key financial KPIs that Orkla and Rhône will be watching?

Nils Selte

executive
#54

I believe this is very much a case of, as Øyvind mentioned, having aligned—we've delved into the strategic plans for Orkla Food Ingredients jointly. Both sides are committed going forward. My sense is the KPIs will remain largely the same in the future. With luck, we'll be able to perform better against those KPIs. First and foremost... I think it's fair to describe Orkla Food Ingredients as something of a standout within Orkla over recent years. And hopefully, under the new ownership, they'll keep being a standout and deliver well on the key important KPIs. We'll come back to this at the Capital Markets Day as well, providing more precision on the strategy for Orkla Food Ingredients and how they'll execute it, along with the most important KPIs.

Øyvind Torpp

executive
#55

Yeah. I really can't wait to lay out the plans and the targets at the Capital Markets Day at the end of November. But broadly speaking, I think we're going to be placing more emphasis on cash flow across all our companies, Orkla Food Ingredients included, than we did in earlier years.

Kari Lindtvedt

executive
#56

That's a fair point. That wrapped up the question from the web. Are there any further questions from the audience? No, it doesn't look like there are. Thanks, everyone, for being with us today, and please don't forget to mark your calendars for our Capital Markets Day on the 29th of November. Thanks for joining us today.

Read the full transcript via the API

You're viewing the first half of this call. Get the complete Orkla ASA transcript — plus 132,000+ transcripts from 7,000+ companies, speaker segments, AI summaries and full-text search — through the EarningsCalls.dev API.

Get the API View API docs →

This call discussed

For developers and AI pipelines

Programmatic access to Orkla ASA earnings transcripts and 132,000+ others is available through the EarningsCalls.dev REST API. Plans from $39.99/month — full transcripts, speaker segments, full-text search, and the recently-added /api/v1/transcripts/recent polling endpoint for ETL pipelines.

More tools for stock research

OptionsBell: an unusual options activity scanner that tracks options flow across all US stocks and emails you when large trades appear in Orkla ASA or any ticker on your watchlist.

StockMarketScan: a stock screener with alerts: 24 pre-built screens refreshed every 5 minutes, watchlists and email notifications. Both offer API and MCP access and fair monthly pricing.